First report on multidrug-resistant non-encapsulated Streptococcus pneumoniae isolated from a patient with pneumonia
The non-encapsulated Streptococcus pneumoniae (NESp) has emerged and increased in the clinical setting. The majority of NESp strains have been isolated from the nasopharynxes of healthy carriers and from respiratory specimens of patients with otitis media. NESp strains were shown to be more effectiv...
Gespeichert in:
| Veröffentlicht in: | Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2020-07, Vol.26 (7), p.749-751 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 751 |
|---|---|
| container_issue | 7 |
| container_start_page | 749 |
| container_title | Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy |
| container_volume | 26 |
| creator | Takeuchi, Noriko Ohkusu, Misako Hishiki, Haruka Fujii, Katsunori Hotta, Megumi Murata, Shota Ishiwada, Naruhiko |
| description | The non-encapsulated Streptococcus pneumoniae (NESp) has emerged and increased in the clinical setting. The majority of NESp strains have been isolated from the nasopharynxes of healthy carriers and from respiratory specimens of patients with otitis media. NESp strains were shown to be more effective than encapsulated counterparts at forming biofilms. Therefore, NESp should become one of the leading causes of emerging refractory respiratory disease after the introduction of pneumococcal conjugate vaccines. We report the first case of multidrug-resistant - including fluoroquinolone-resistant - NESp isolated from the intrabronchial aspirate of a patient with pneumonia. Drug-resistant NESp infections can possibly emerge as a clinical problem and thus the continuous monitoring of NESp infections is of utmost importance. |
| doi_str_mv | 10.1016/j.jiac.2020.02.009 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2404039059</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1341321X2030057X</els_id><sourcerecordid>2404039059</sourcerecordid><originalsourceid>FETCH-LOGICAL-c380t-2bd89eb82c091db4977cf198029fd5bfefd660aca046f9b186dddf26db77aa0f3</originalsourceid><addsrcrecordid>eNp9kMFO3DAURa2KqjMFfqCLyks2SZ-dTBJLbBBi2kojdUGR2FmO_QweJXFqO0X8PR4NhV1Xfotzj-RDyBcGJQPWfNuXe6d0yYFDCbwEEB_ImtVVW7RtByf5rmpWVJzdr8jnGPcArN103SeyqngNAphYk7R1ISYacPYhUT_RcRmSM2F5KAJGF5OaEp38VOCk1RyXQSU09DblQfLaa71EOk-4jH5yCqmL_kjY4Eeq6KySw2x4cunxnTsjH60aIp6_vqfkbnvz-_pHsfv1_ef11a7QVQep4L3pBPYd1yCY6WvRttoy0QEX1mx6i9Y0DSitoG6s6FnXGGMsb0zftkqBrU7JxdE7B_9nwZjk6KLGYVAT-iXKXKGGSsBGZJQfUR18jAGtnIMbVXiWDOShttzLQ215qC2By1w7j76--pd-RPM2-Zc3A5dHAPMv_zoMMurcQ6NxAXWSxrv_-V8AlheUtw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2404039059</pqid></control><display><type>article</type><title>First report on multidrug-resistant non-encapsulated Streptococcus pneumoniae isolated from a patient with pneumonia</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Takeuchi, Noriko ; Ohkusu, Misako ; Hishiki, Haruka ; Fujii, Katsunori ; Hotta, Megumi ; Murata, Shota ; Ishiwada, Naruhiko</creator><creatorcontrib>Takeuchi, Noriko ; Ohkusu, Misako ; Hishiki, Haruka ; Fujii, Katsunori ; Hotta, Megumi ; Murata, Shota ; Ishiwada, Naruhiko</creatorcontrib><description>The non-encapsulated Streptococcus pneumoniae (NESp) has emerged and increased in the clinical setting. The majority of NESp strains have been isolated from the nasopharynxes of healthy carriers and from respiratory specimens of patients with otitis media. NESp strains were shown to be more effective than encapsulated counterparts at forming biofilms. Therefore, NESp should become one of the leading causes of emerging refractory respiratory disease after the introduction of pneumococcal conjugate vaccines. We report the first case of multidrug-resistant - including fluoroquinolone-resistant - NESp isolated from the intrabronchial aspirate of a patient with pneumonia. Drug-resistant NESp infections can possibly emerge as a clinical problem and thus the continuous monitoring of NESp infections is of utmost importance.</description><identifier>ISSN: 1341-321X</identifier><identifier>EISSN: 1437-7780</identifier><identifier>DOI: 10.1016/j.jiac.2020.02.009</identifier><identifier>PMID: 32409019</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Adolescent ; Ampicillin - pharmacology ; Ampicillin - therapeutic use ; Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; Cefozopran ; Cephalosporins - therapeutic use ; Drug Resistance, Multiple, Bacterial - genetics ; Drug Therapy, Combination ; Female ; Humans ; Microbial Sensitivity Tests ; Multidrug-resistant ; Myopathies, Structural, Congenital ; Non-encapsulated Streptococcus pneumoniae ; Ophthalmoplegia ; Pneumococcal surface protein K (pspK) ; Pneumonia, Pneumococcal - diagnosis ; Pneumonia, Pneumococcal - drug therapy ; Pneumonia, Pneumococcal - microbiology ; Quinolone resistance-determining region (QRDR) ; Ryanodine Receptor Calcium Release Channel - deficiency ; Sputum - microbiology ; Streptococcus pneumoniae - drug effects ; Streptococcus pneumoniae - genetics ; Streptococcus pneumoniae - isolation & purification ; Sulbactam - pharmacology ; Sulbactam - therapeutic use</subject><ispartof>Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2020-07, Vol.26 (7), p.749-751</ispartof><rights>2020 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases</rights><rights>Copyright © 2020 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c380t-2bd89eb82c091db4977cf198029fd5bfefd660aca046f9b186dddf26db77aa0f3</citedby><cites>FETCH-LOGICAL-c380t-2bd89eb82c091db4977cf198029fd5bfefd660aca046f9b186dddf26db77aa0f3</cites><orcidid>0000-0003-3659-865X ; 0000-0002-7508-1330</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32409019$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Takeuchi, Noriko</creatorcontrib><creatorcontrib>Ohkusu, Misako</creatorcontrib><creatorcontrib>Hishiki, Haruka</creatorcontrib><creatorcontrib>Fujii, Katsunori</creatorcontrib><creatorcontrib>Hotta, Megumi</creatorcontrib><creatorcontrib>Murata, Shota</creatorcontrib><creatorcontrib>Ishiwada, Naruhiko</creatorcontrib><title>First report on multidrug-resistant non-encapsulated Streptococcus pneumoniae isolated from a patient with pneumonia</title><title>Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy</title><addtitle>J Infect Chemother</addtitle><description>The non-encapsulated Streptococcus pneumoniae (NESp) has emerged and increased in the clinical setting. The majority of NESp strains have been isolated from the nasopharynxes of healthy carriers and from respiratory specimens of patients with otitis media. NESp strains were shown to be more effective than encapsulated counterparts at forming biofilms. Therefore, NESp should become one of the leading causes of emerging refractory respiratory disease after the introduction of pneumococcal conjugate vaccines. We report the first case of multidrug-resistant - including fluoroquinolone-resistant - NESp isolated from the intrabronchial aspirate of a patient with pneumonia. Drug-resistant NESp infections can possibly emerge as a clinical problem and thus the continuous monitoring of NESp infections is of utmost importance.</description><subject>Adolescent</subject><subject>Ampicillin - pharmacology</subject><subject>Ampicillin - therapeutic use</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Cefozopran</subject><subject>Cephalosporins - therapeutic use</subject><subject>Drug Resistance, Multiple, Bacterial - genetics</subject><subject>Drug Therapy, Combination</subject><subject>Female</subject><subject>Humans</subject><subject>Microbial Sensitivity Tests</subject><subject>Multidrug-resistant</subject><subject>Myopathies, Structural, Congenital</subject><subject>Non-encapsulated Streptococcus pneumoniae</subject><subject>Ophthalmoplegia</subject><subject>Pneumococcal surface protein K (pspK)</subject><subject>Pneumonia, Pneumococcal - diagnosis</subject><subject>Pneumonia, Pneumococcal - drug therapy</subject><subject>Pneumonia, Pneumococcal - microbiology</subject><subject>Quinolone resistance-determining region (QRDR)</subject><subject>Ryanodine Receptor Calcium Release Channel - deficiency</subject><subject>Sputum - microbiology</subject><subject>Streptococcus pneumoniae - drug effects</subject><subject>Streptococcus pneumoniae - genetics</subject><subject>Streptococcus pneumoniae - isolation & purification</subject><subject>Sulbactam - pharmacology</subject><subject>Sulbactam - therapeutic use</subject><issn>1341-321X</issn><issn>1437-7780</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMFO3DAURa2KqjMFfqCLyks2SZ-dTBJLbBBi2kojdUGR2FmO_QweJXFqO0X8PR4NhV1Xfotzj-RDyBcGJQPWfNuXe6d0yYFDCbwEEB_ImtVVW7RtByf5rmpWVJzdr8jnGPcArN103SeyqngNAphYk7R1ISYacPYhUT_RcRmSM2F5KAJGF5OaEp38VOCk1RyXQSU09DblQfLaa71EOk-4jH5yCqmL_kjY4Eeq6KySw2x4cunxnTsjH60aIp6_vqfkbnvz-_pHsfv1_ef11a7QVQep4L3pBPYd1yCY6WvRttoy0QEX1mx6i9Y0DSitoG6s6FnXGGMsb0zftkqBrU7JxdE7B_9nwZjk6KLGYVAT-iXKXKGGSsBGZJQfUR18jAGtnIMbVXiWDOShttzLQ215qC2By1w7j76--pd-RPM2-Zc3A5dHAPMv_zoMMurcQ6NxAXWSxrv_-V8AlheUtw</recordid><startdate>202007</startdate><enddate>202007</enddate><creator>Takeuchi, Noriko</creator><creator>Ohkusu, Misako</creator><creator>Hishiki, Haruka</creator><creator>Fujii, Katsunori</creator><creator>Hotta, Megumi</creator><creator>Murata, Shota</creator><creator>Ishiwada, Naruhiko</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3659-865X</orcidid><orcidid>https://orcid.org/0000-0002-7508-1330</orcidid></search><sort><creationdate>202007</creationdate><title>First report on multidrug-resistant non-encapsulated Streptococcus pneumoniae isolated from a patient with pneumonia</title><author>Takeuchi, Noriko ; Ohkusu, Misako ; Hishiki, Haruka ; Fujii, Katsunori ; Hotta, Megumi ; Murata, Shota ; Ishiwada, Naruhiko</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c380t-2bd89eb82c091db4977cf198029fd5bfefd660aca046f9b186dddf26db77aa0f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adolescent</topic><topic>Ampicillin - pharmacology</topic><topic>Ampicillin - therapeutic use</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Cefozopran</topic><topic>Cephalosporins - therapeutic use</topic><topic>Drug Resistance, Multiple, Bacterial - genetics</topic><topic>Drug Therapy, Combination</topic><topic>Female</topic><topic>Humans</topic><topic>Microbial Sensitivity Tests</topic><topic>Multidrug-resistant</topic><topic>Myopathies, Structural, Congenital</topic><topic>Non-encapsulated Streptococcus pneumoniae</topic><topic>Ophthalmoplegia</topic><topic>Pneumococcal surface protein K (pspK)</topic><topic>Pneumonia, Pneumococcal - diagnosis</topic><topic>Pneumonia, Pneumococcal - drug therapy</topic><topic>Pneumonia, Pneumococcal - microbiology</topic><topic>Quinolone resistance-determining region (QRDR)</topic><topic>Ryanodine Receptor Calcium Release Channel - deficiency</topic><topic>Sputum - microbiology</topic><topic>Streptococcus pneumoniae - drug effects</topic><topic>Streptococcus pneumoniae - genetics</topic><topic>Streptococcus pneumoniae - isolation & purification</topic><topic>Sulbactam - pharmacology</topic><topic>Sulbactam - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Takeuchi, Noriko</creatorcontrib><creatorcontrib>Ohkusu, Misako</creatorcontrib><creatorcontrib>Hishiki, Haruka</creatorcontrib><creatorcontrib>Fujii, Katsunori</creatorcontrib><creatorcontrib>Hotta, Megumi</creatorcontrib><creatorcontrib>Murata, Shota</creatorcontrib><creatorcontrib>Ishiwada, Naruhiko</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Takeuchi, Noriko</au><au>Ohkusu, Misako</au><au>Hishiki, Haruka</au><au>Fujii, Katsunori</au><au>Hotta, Megumi</au><au>Murata, Shota</au><au>Ishiwada, Naruhiko</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>First report on multidrug-resistant non-encapsulated Streptococcus pneumoniae isolated from a patient with pneumonia</atitle><jtitle>Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy</jtitle><addtitle>J Infect Chemother</addtitle><date>2020-07</date><risdate>2020</risdate><volume>26</volume><issue>7</issue><spage>749</spage><epage>751</epage><pages>749-751</pages><issn>1341-321X</issn><eissn>1437-7780</eissn><abstract>The non-encapsulated Streptococcus pneumoniae (NESp) has emerged and increased in the clinical setting. The majority of NESp strains have been isolated from the nasopharynxes of healthy carriers and from respiratory specimens of patients with otitis media. NESp strains were shown to be more effective than encapsulated counterparts at forming biofilms. Therefore, NESp should become one of the leading causes of emerging refractory respiratory disease after the introduction of pneumococcal conjugate vaccines. We report the first case of multidrug-resistant - including fluoroquinolone-resistant - NESp isolated from the intrabronchial aspirate of a patient with pneumonia. Drug-resistant NESp infections can possibly emerge as a clinical problem and thus the continuous monitoring of NESp infections is of utmost importance.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>32409019</pmid><doi>10.1016/j.jiac.2020.02.009</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0003-3659-865X</orcidid><orcidid>https://orcid.org/0000-0002-7508-1330</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1341-321X |
| ispartof | Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2020-07, Vol.26 (7), p.749-751 |
| issn | 1341-321X 1437-7780 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2404039059 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Adolescent Ampicillin - pharmacology Ampicillin - therapeutic use Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Cefozopran Cephalosporins - therapeutic use Drug Resistance, Multiple, Bacterial - genetics Drug Therapy, Combination Female Humans Microbial Sensitivity Tests Multidrug-resistant Myopathies, Structural, Congenital Non-encapsulated Streptococcus pneumoniae Ophthalmoplegia Pneumococcal surface protein K (pspK) Pneumonia, Pneumococcal - diagnosis Pneumonia, Pneumococcal - drug therapy Pneumonia, Pneumococcal - microbiology Quinolone resistance-determining region (QRDR) Ryanodine Receptor Calcium Release Channel - deficiency Sputum - microbiology Streptococcus pneumoniae - drug effects Streptococcus pneumoniae - genetics Streptococcus pneumoniae - isolation & purification Sulbactam - pharmacology Sulbactam - therapeutic use |
| title | First report on multidrug-resistant non-encapsulated Streptococcus pneumoniae isolated from a patient with pneumonia |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T23%3A03%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=First%20report%20on%20multidrug-resistant%20non-encapsulated%20Streptococcus%20pneumoniae%20isolated%20from%20a%20patient%20with%20pneumonia&rft.jtitle=Journal%20of%20infection%20and%20chemotherapy%20:%20official%20journal%20of%20the%20Japan%20Society%20of%20Chemotherapy&rft.au=Takeuchi,%20Noriko&rft.date=2020-07&rft.volume=26&rft.issue=7&rft.spage=749&rft.epage=751&rft.pages=749-751&rft.issn=1341-321X&rft.eissn=1437-7780&rft_id=info:doi/10.1016/j.jiac.2020.02.009&rft_dat=%3Cproquest_cross%3E2404039059%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2404039059&rft_id=info:pmid/32409019&rft_els_id=S1341321X2030057X&rfr_iscdi=true |